Luis Martinez Agulleiro

Dr. Luis Martinez Agulleiro

New York University, New York, USA
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 September 2023 in Psychological Medicine
Verified
Journal Article
Open access
PDF file
CSchelsea sawyer
chelsea sawyer
GMGrace McKeon
Grace McKeon
LHLamiece Hassan
Lamiece Hassan
HOHenry Onyweaka
Henry Onyweaka
LALuis Martinez Agulleiro
Luis Martinez Agulleiro
JFJoseph Firth
Joseph Firth
The use of digital technologies as a method of delivering health behaviour change (HBC) interventions is rapidly increasing across the general population. However, the role in severe mental illness (SMI) remains overlooked. In this study, we aimed to systematically identify and evaluate all of the existing evidence around digital HBC interventions in people with an SMI. A systematic search of online electronic databases was conducted. Data on adherence, feasibility, and outcomes of studies on digital HBC interventions in SMI were extracted. Our combined search identified 2196 titles and abstracts, of which 1934 remained after removing duplicates. Full-text screening was performed for 107 articles, leaving 36 studies to be included. From these, 14 focused on physical activity and/or cardio-metabolic health, 19 focused on smoking cessation, and three concerned other health behaviours. The outcomes measured varied considerably across studies. Although over 90% of studies measuring behavioural changes reported positive changes in behaviour/attitudes, there were too few studies collecting data on mental health to determine effects on psychiatric outcomes. Digital HBC interventions are acceptable to people with an SMI, and could present a promising option for addressing behavioural health in these populations. Feedback indicated that additional human support may be useful for promoting adherence/engagement, and the content of such interventions may benefit from more tailoring to specific needs. While the literature does not yet allow for conclusions regarding efficacy for mental health, the available evidence to date does support their potential to change behaviour across various domains.

10 May 2023 in Psychological Medicine
Verified
Journal Article
Open access
PDF file
LALuis Martinez Agulleiro
Luis Martinez Agulleiro
BPBhagyashree Patil
Bhagyashree Patil
JFJoseph Firth
Joseph Firth
CSChelsea Sawyer
Chelsea Sawyer
BABenedikt L. Amann
Benedikt L. Amann
DGDaniel Guinart
Daniel Guinart
Tobacco smoking is highly prevalent among patients with serious mental illness (SMI), with known deleterious consequences. Smoking cessation is therefore a prioritary public health challenge in SMI. In recent years, several smoking cessation digital interventions have been developed for non-clinical populations. However, their impact in patients with SMI remains uncertain. We conducted a systematic review to describe and evaluate effectiveness, acceptability, adherence, usability and safety of digital interventions for smoking cessation in patients with SMI. PubMed/MEDLINE, EMBASE, CINAHL, Web of Science, PsychINFO and the Cochrane Tobacco Addiction Group Specialized Register were searched. Studies matching inclusion criteria were included and their information systematically extracted by independent investigators. Thirteen articles were included, which reported data on nine different digital interventions. Intervention theoretical approaches ranged from mobile contingency management to mindfulness. Outcome measures varied widely between studies. The highest abstinence rates were found for mSMART MIND (7-day point-prevalent abstinence: 16–40%). Let's Talk About Quitting Smoking reported greater acceptability ratings, although this was not evaluated with standardized measures. Regarding usability, Learn to Quit showed the highest System Usability Scale scores [mean (s.d.) 85.2 (15.5)]. Adverse events were rare and not systematically reported. Overall, the quality of the studies was fair to good. Digitally delivered health interventions for smoking cessation show promise for improving outcomes for patients with SMI, but lack of availability remains a concern. Larger trials with harmonized assessment measures are needed to generate more definitive evidence and specific recommendations.

1 August 2022 in Behavioral Sciences
Verified
Journal Article
Open access
PDF file
CSchelsea sawyer
chelsea sawyer
LHLamiece Hassan
Lamiece Hassan
DGDaniel Guinart
Daniel Guinart
LALuis Martinez Agulleiro
Luis Martinez Agulleiro
JFJoseph Firth
Joseph Firth
Background: The large health disparities among those diagnosed with schizophrenia urgently need to be addressed. These disparities are partially caused by adverse health behaviours such as smoking. Smoking cessation apps vary in efficacy across various populations, and there are concerns regarding the accessibility and usability of apps for people with schizophrenia. Objective: This review identifies and examines the feasibility of using apps for smoking cessation in people with schizophrenia. Methods: A non-systematic narrative literature review of smoking cessation apps for individuals with schizophrenia was performed. Results: Eight studies were included in this review. Conclusion: Smoking cessation apps can be acceptable and feasible, but may need to be tailored to the needs of people with schizophrenia. Key messages: (1) Smoking cessation apps could be acceptable and feasible for use in people with schizophrenia; (2) Lack of motivation was perceived as the main potential barrier with regard to people with schizophrenia engaging with smoking cessation apps; (3) In order to improve motivation of people diagnosed with schizophrenia, apps could include games, rewards, and/or social support; (4) Smoking cessation apps with a simple interface seem to be beneficial for this population; (5) Apps may need to be tailored to consider this population’s mental health needs.

17 November 2021 in Australian & New Zealand Journal of Psychiatry
Verified
Journal Article
Closed access
PDF file
LALuis Martinez Agulleiro
Luis Martinez Agulleiro
RFRenato de Filippis
Renato de Filippis
SRStella Rosson
Stella Rosson
BPBhagyashree Patil
Bhagyashree Patil
LPLara Prizgint
Lara Prizgint
DGDaniel Guinart
Daniel Guinart
Self-reports or patient-reported outcome measures are seldom used in psychosis due to concerns about the ability of patients to accurately report their symptomatology, particularly in cases of low awareness of illness. The aim of this study was to assess the effect of insight on the accuracy of self-reported psychotic symptoms using a computerized adaptive testing tool (CAT-Psychosis). A secondary analysis of data drawn from the CAT-Psychosis development and validation study was performed. The Brief Psychiatric Rating Scale and the Scale of Unawareness of Mental Disorders were administered by clinicians. Patients completed the self-reported version of the CAT-Psychosis. Patients were median-split regarding their insight level to compare the correlation between the two psychosis severity measures. A subgroup sensitivity analysis was performed only on patients with schizophrenia spectrum disorders. A total of 159 patients with a psychotic disorder who completed both CAT-Psychosis and Scale of Unawareness of Mental Disorders were included. For the whole sample, CAT-Psychosis scores showed convergent validity with Brief Psychiatric Rating Scale ratings (r = 0.517, 95% confidence interval = [0.392, 0.622], p < 0.001). Insight was found to moderate this correlation (β = –0.511, p = 0.005), yet agreement between both measures remained statistically significant for both high (r = 0.621, 95% confidence interval = [0.476, 0.733], p < 0.001) and low insight patients (r = 0.408, 95% confidence interval = [0.187, 0.589], p < 0.001), while psychosis severity was comparable between these groups (for Brief Psychiatric Rating Scale: U = 3057, z = –0.129, p = 0.897; disorganization: U = 2986.5, z = –0.274, p = 0.784 and for CAT-Psychosis: U = 2800.5, z = –1.022, p = 0.307). Subgroup of patients with schizophrenia spectrum disorders showed very similar results. Insight moderates the correlation between self-reported and clinician-rated severity of psychosis, yet CAT-Psychosis remains valid in patients with both high and low awareness of illness.

17 April 2025 in Pediatric Emergency Care
Verified
Journal Article
Closed access
LALuis Martinez Agulleiro
Luis Martinez Agulleiro
MKMehmet Utku Kucuker
Mehmet Utku Kucuker
FGFei Guo
Fei Guo
AJAron Janssen
Aron Janssen
CSCheryl R. Stein
Cheryl R. Stein
ABArgelinda Baroni
Argelinda Baroni
Objectives: To document the proportion of transgender and gender diverse (TGD) youth presenting to a pediatric psychiatric emergency department (ED) and examine whether their demographic and clinical characteristics differ from cisgender youth. Methods: We analyzed electronic health records of youth ages 5 to 17 years presenting to a specialized pediatric psychiatric ED (N = 2728), including sociodemographic characteristics, gender identity, suicidal risk at admission, and diagnoses at discharge. We examined differences by gender identity using χ2 tests (categorical variables), 2-sample t tests, or Mann-Whitney U tests (continuous variables). Adjusted Poisson regression models estimated the prevalence ratio of the association between gender identity and clinical diagnoses. Results: Of youth, 6% seeking emergency psychiatric care identified as TGD. Compared with cisgender peers, TGD youth exhibited a higher risk for suicide, longer hospital stays, and received more psychiatric diagnoses at discharge, including a higher prevalence of suicidal thoughts and behaviors (prevalence ratio: 1.50, 95% CI: 1.16, 1.90). Conclusions: TGD youth have more severe clinical presentations in the psychiatric ED compared with cisgender youth. Further research is essential to develop targeted interventions to support the mental health of TGD youth.

4 October 2025 in Neuropsychopharmacology
Verified
Journal Article
Open access
PDF file
CFCourtney Filippi
Courtney Filippi
AMAlice Massera
Alice Massera
JXJiayin Xing
Jiayin Xing
LALuis Martinez Agulleiro
Luis Martinez Agulleiro
This review showcases the ways that studying the neural basis of Behavioral Inhibition (BI) and maternal anxiety in infancy has advanced our understanding of the developmental pathophysiology of anxiety. We demonstrate that infants with BI and those who have been exposed to maternal anxiety/stress exhibit differences in neural processes associated with bottom-up attention and top-down control, both when we measure the brain at rest and when we measure the brain during stimulus processing. Differences in infant stimulus processing are particularly robust—not only do they emerge in at-risk infants, but they also shape risk trajectories from infancy through adolescence. Throughout this review, we underscore the value in a focus on infancy and early childhood. We also point to several key future directions for this work, including prioritizing a longitudinal, multi-modal approach for studying neurobehavioral profiles of early-life risk. Together, this work demonstrates that neural processes involved in attention and control are central to BI and early-life risk for anxiety across the lifespan.